November 12, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Sarepta Therapeutics Inc (NASDAQ:SRPT) shares over potential securities laws violations Sarepta Therapeutics Inc. and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Sarepta Therapeutics Inc (NASDAQ:SRPT) concerning whether a series of statements by Sarepta Therapeutics Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Sarepta Therapeutics Inc reported that its quarterly Revenue declined from $7.34 million in the fourth quarter 2012 to $4.47 million in the first and $2.95 million in the second quarter 2013, while its Net Loss decreased over those quarters from $62.07 million to $42.08 million, respectively $19.05 million.

Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) grew from under $24 in early 2013 to as high as $53.81 per share in October 2013.

Then on November 12, 2013, Sarepta Therapeutics Inc reported its third quarter 2013 finanical results. Among other

Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) dropped from $37.74 per share on November 11, 2013, to $13.16 per share on November 12, 2013.